SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

2.

Prostate cancer early detection system eliminates need for biopsy.

3.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

4.

November 2023, Medical Bulletin 04/.

5.

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot